In that work, we also used SMRT sequencing to demonstrate that TP53 variants were always distributed in different alleles in acute lymphocytic leukemia (ALL) and myelodysplastic syndrome (MDS), confirming the clonal heterogeneity of those tumors. The gene discussed is TP53; the disease is acute lymphoblastic leukemia.